Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 618

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1
Chunk 618
---
.

Board
Oversight

While
the Board of Directors has overall responsibility for risk oversight, our Audit Committee oversees cybersecurity risk matters. The Audit
Committee is responsible for reviewing, discussing with management, and overseeing the Company’s cybersecurity and privacy risk
exposures and policies. On a quarterly basis, the CTO reports to the Audit Committee on information technology and cybersecurity matters,
including key information technology risks. The CTO also apprises the Audit Committee and full Board of cyber security incidents consistent
with our incident response program, promptly.

Cybersecurity
Risks

Our
cybersecurity risk management processes are integrated into our overall Enterprise Risk Management (“ERM”) process. As part
of our ERM process, department leaders identify, assess, and evaluate risks impacting our operations across the Company, including those
risks related to cybersecurity. Department leaders are asked to consider the severity and likelihood of certain risk factors, drawing
upon their company knowledge and past business experience. While we maintain a robust cybersecurity program, the techniques used to infiltrate
information technology systems continue to evolve. Accordingly, we may not be able to timely detect threats or anticipate and implement
adequate security measures. For additional information, see “Item 1A—Risk Factors.” To date, we have not experienced
any material cybersecurity incidents or threats.

ITEM 2. PROPERTIES

As of June 18, 2025, the Company
leased facilities for corporate and R&D purposes at locations throughout the United States and in various locations outside of the
United States. Our executive office is located at 900 Stewart Avenue, Suite 310, Garden City, NY 11530, and is under a lease that expires
in June 2031. We have an office in Dublin, Ireland under a lease that expires in September 2028 and an office space in Rehovot, Israel
under a lease that expires over the course of the next fiscal year. The Company has a research and development facility in Madison, Wisconsin
under a lease that expires in May 2026. The Company believes the existing facilities which are used by all reportable segments of the
Company and are in good operating condition and are suitable for the conduct of its business.

ITEM 3. LEGAL PROCEEDINGS

From time to time, the Company
is involved in various legal matters arising in the normal course of business. Litigation and other disputes are inherently unpredictable
and subject to substantial uncertainties and unfavorable resolutions could occur. At the same time,